Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)

- Updates from the 46th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors - What’s New in the Treatment of ER, PR and HER2 Positive Breast Cancer - Updates from SABCS on: Hormone & Targeted Therapy - Chemotherapy Updates from SABCS - Investigational New Drugs in Clinical Trials - What’s New in Prevention & Management of Treatment Side Effects, Discomfort, Neuropathy & Long Term Effects - Questions to Ask Your Health Care Team - Questions for Our Panel of Experts